Literature DB >> 18805741

Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia?

Andrea Steinborn1, Gertrud M Haensch, Karsten Mahnke, Edgar Schmitt, Anne Toermer, Stefan Meuer, Christof Sohn.   

Abstract

Regulatory T cells (CD4(+)CD25(+)FoxP3(+)-Treg cells) are important regulators of tolerance induction during pregnancy. We now found that the number of CD4(+)CD25(+)FoxP3(+)-Treg cells decreases during normal course of pregnancy and even more so in women affected by preeclampsia. The functional activity of these CD4(+)CD25(+)-Treg cells was significantly reduced in comparison to those of healthy pregnants. Further analysis revealed two Treg subsets that differed with regard to the FoxP3 and CD25 expression. The percentage of both, CD4(+)CD25(+)FoxP3(high+)-Treg and CD4(+)CD25(high+)FoxP3(+), was maximal in the first and second trimenon, but declined severely in the third trimenon. In preeclamptic women the population of CD4(+)CD25(high+)FoxP3(+)-Treg cells was particularly apparent, while the population of CD4(+)CD25(+)FoxP3(high+)-Treg cells was significantly decreased. We propose that CD4(+)CD25(+)FoxP3(high+)- and CD4(+)CD25(high+)FoxP3(+)-Treg cell populations represent distinct Treg cell subsets, and that disturbances in the balance of these two Treg cell subsets are associated with the presence of preeclampsia, but not HELLP-syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805741     DOI: 10.1016/j.clim.2008.07.032

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  35 in total

1.  Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs.

Authors:  A Steinborn; E Schmitt; A Kisielewicz; S Rechenberg; N Seissler; K Mahnke; M Schaier; M Zeier; C Sohn
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

2.  Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties.

Authors:  Henrieta Papuchova; Sarika Kshirsagar; Lily Xu; Hannah A Bougleux Gomes; Qin Li; Vidya Iyer; Errol R Norwitz; Jack L Strominger; Tamara Tilburgs
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-24       Impact factor: 11.205

Review 3.  Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.

Authors:  Christian Morath; Anita Schmitt; Florian Kälble; Martin Zeier; Michael Schmitt; Flavius Sandra-Petrescu; Gerhard Opelz; Peter Terness; Matthias Schaier; Christian Kleist
Journal:  Pediatr Nephrol       Date:  2017-02-23       Impact factor: 3.714

Review 4.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

5.  Dysregulation of the Fas/FasL system in an experimental animal model of HELLP syndrome.

Authors:  Jacob Gibbens; Rachael Morris; Teylor Bowles; Shauna-Kay Spencer; Kedra Wallace
Journal:  Pregnancy Hypertens       Date:  2017-02-24       Impact factor: 2.899

6.  The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia.

Authors:  Yonghong Zhang; Zhaozhao Liu; Mei Tian; Xiaohui Hu; Liling Wang; Jinlu Ji; Aihua Liao
Journal:  Cell Mol Immunol       Date:  2017-09-11       Impact factor: 11.530

7.  Decidual vascular endothelial cells promote maternal-fetal immune tolerance by inducing regulatory T cells through canonical Notch1 signaling.

Authors:  Yanyi Yao; Jieping Song; Weipeng Wang; Nian Liu
Journal:  Immunol Cell Biol       Date:  2015-12-30       Impact factor: 5.126

8.  Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome.

Authors:  Kedra Wallace; Rachael Morris; Patrick B Kyle; Denise Cornelius; Marie Darby; Jeremy Scott; Janae Moseley; Krystal Chatman; Babbette Lamarca
Journal:  Hypertens Pregnancy       Date:  2014-02       Impact factor: 2.108

9.  Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation.

Authors:  Alan Leviton; Raina Fichorova; Yoshika Yamamoto; Elizabeth N Allred; Olaf Dammann; Jonathan Hecht; Karl Kuban; Thomas McElrath; T Michael O'Shea; Nigel Paneth
Journal:  Cytokine       Date:  2010-10-08       Impact factor: 3.861

Review 10.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.